Flex Biomedical is a privately-held, angel and venture-backed company based in Madison, Wisconsin. Current investors include NEW Capital Fund, Wisconsin Investment Partners and the Marquette Golden Angels Network.

In 2008 the company received a $175,000 Small Business Innovation Research (SBIR) grant from the National Institutes of Health. In 2009 Flex Biomedical was also awarded a $150,000 Technology Venture Fund Loan from the state of Wisconsin.

Wisconsin Governor Jim Doyle said, "Flex Biomedical is exactly the type of company our state should be investing in - companies that are developing innovative products that will create jobs for hardworking Wisconsin families."

Flex Biomedical is a Wisconsin Qualified New Business Venture - investors receive a 25% tax credit from Wisconsin.

Please contact CEO Sal Braico at (608) 213-8246 or sbraico@flexbio.com if you are interested in learning more.

27 million people have Osteoarthritis (OA) in the US with direct annual cost of $70 billion.